×
About 3,561 results

ALLMedicine™ Chronic Urticaria Center

Research & Reviews  1,225 results

Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.
https://doi.org/10.23822/EurAnnACI.1764-1489.209
European Annals of Allergy and Clinical Immunology; Esteves Caldeira L, Paulino M et. al.

May 5th, 2021 - Background. Chronic urticaria (CU) is a frequent disease, with a prevalence of at least 1%. It is characterized by pruritic wheals, angioedema or both for a period longer than 6 weeks. Objective. Identify the demographic, clinical, laboratory and ...

Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled ...
https://doi.org/10.23822/EurAnnACI.1764-1489.200
European Annals of Allergy and Clinical Immunology; Atefi N, Fallahpour M et. al.

May 3rd, 2021 - Background. Chronic spontaneous urticaria (CSU) is a common and treatment challenging disorder which may involve about 2% of normal population and in 50% do not respond properly even to the second line therapies. We aimed to evaluate the efficacy ...

Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria.
https://doi.org/10.1159/000515753
International Archives of Allergy and Immunology; Zhang Y, Zhang H et. al.

Apr 29th, 2021 - Urticaria is a type of skin disease characterized by rapid onset of hives (superficial dermis edema, erythema, pruritus, or burning sensation). According to whether the natural course exceeds 6 weeks, urticaria can be divided into acute and chroni...

Effect of omalizumab treatment on peripheral nerves in patients with chronic spontaneou...
https://doi.org/10.1080/15569527.2021.1914076
Cutaneous and Ocular Toxicology; Altunisik E, Inan Dogan E

Apr 27th, 2021 - Aim: Chronic spontaneous urticaria (CSU) is characterised by itchy, red and raised lesions that appear as an attack without any cause and last for six weeks or longer. Omalizumab is a humanised monoclonal antibody that selectively binds to the Ce3...

Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticari...
https://doi.org/10.1159/000514757
International Archives of Allergy and Immunology; Miles LM, Gabrielli S et. al.

Apr 1st, 2021 - Some forms of chronic urticaria (CU) can be specifically attributed to a response to a definite trigger, referred to as chronic inducible urticaria (CIndU). We aimed to assess the demographics, clinical characteristics, comorbidities, natural hist...

see more →

Guidelines  3 results

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the Britis... Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

AAITO Position paper. Chronic urticaria: diagnostic workup and treatment.
https://www.ncbi.nlm.nih.gov/pubmed/18236998
European Annals of Allergy and Clinical Immunology; Tedeschi A, Girolomoni G et. al.

Feb 1st, 2008 - AAITO Position paper. Chronic urticaria: diagnostic workup and treatment.|2008|Tedeschi A,Girolomoni G,Asero R, ,|complications,therapeutic use,therapeutic use,therapeutic use,diagnosis,epidemiology,etiology,physiopathology,therapy,

see more →

Drugs  495 results see all →

Clinicaltrials.gov  1,761 results

Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.
https://doi.org/10.23822/EurAnnACI.1764-1489.209
European Annals of Allergy and Clinical Immunology; Esteves Caldeira L, Paulino M et. al.

May 5th, 2021 - Background. Chronic urticaria (CU) is a frequent disease, with a prevalence of at least 1%. It is characterized by pruritic wheals, angioedema or both for a period longer than 6 weeks. Objective. Identify the demographic, clinical, laboratory and ...

Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled ...
https://doi.org/10.23822/EurAnnACI.1764-1489.200
European Annals of Allergy and Clinical Immunology; Atefi N, Fallahpour M et. al.

May 3rd, 2021 - Background. Chronic spontaneous urticaria (CSU) is a common and treatment challenging disorder which may involve about 2% of normal population and in 50% do not respond properly even to the second line therapies. We aimed to evaluate the efficacy ...

Hydroxyzine hydrochloride - hydroxyzine hydrochloride tablet, film coated-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=949cb606-6882-4069-bedf-ebf395526ef1

May 2nd, 2021 - For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and ...

Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria.
https://doi.org/10.1159/000515753
International Archives of Allergy and Immunology; Zhang Y, Zhang H et. al.

Apr 29th, 2021 - Urticaria is a type of skin disease characterized by rapid onset of hives (superficial dermis edema, erythema, pruritus, or burning sensation). According to whether the natural course exceeds 6 weeks, urticaria can be divided into acute and chroni...

Hydroxyzine hydrochloride - hydroxyzine hydrochloride tablet-Northwind Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c134195e-a048-530a-e053-2a95a90ad9f8

Apr 29th, 2021 - For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and ...

see more →

News  77 results

Fast Five Quiz: Chronic Spontaneous Urticaria
https://reference.medscape.com/viewarticle/920709

Jun 14th, 2020 - Chronic spontaneous urticaria (CSU) (also referred to as "chronic idiopathic urticaria") represents the majority of cases of chronic urticaria. CSU is defined as chronic urticaria of known or unknown etiology lasting for ≥ 6 weeks. In a subset of ...

Ligelizumab May Improve Response in Chronic Urticaria
https://www.medscape.com/viewarticle/919360

Oct 2nd, 2019 - In the fight against chronic hives, the humanized anti-IgE monoclonal antibody ligelizumab may pack a more powerful punch than omalizumab (Xolar, Genentech), the previous top contender for trapping IgE antibodies for patients with chronic spontane...

Chronic urticaria population identified
https://www.mdedge.com/dermatology/article/199593/urticaria/chronic-urticaria-population-identified?channel=310
Richard Franki

Apr 25th, 2019 - Half a million people. That’s pretty close to the population of Sacramento.

Ligelizumab maintains urticaria control for up to 1 year
https://www.mdedge.com/dermatology/article/198549/urticaria/ligelizumab-maintains-urticaria-control-1-year?channel=310
Michele G. Sullivan

Apr 9th, 2019 - WASHINGTON – Patients with spontaneous chronic urticaria treated with the investigational anti-IgE monoclonal antibody ligelizumab experienced up to a year of symptom control in an open-label extension study, Diane Baker, MD, said at the annual me.

Choose your steps for treating chronic spontaneous urticaria
https://www.mdedge.com/dermatology/article/192975/urticaria/choose-your-steps-treating-chronic-spontaneous-urticaria
Kari Oakes

Jan 18th, 2019 - GRAND CAYMAN, CAYMAN ISLANDS – Large doses of nonsedating second-generation antihistamines are at the heart of treating chronic urticaria and will adequately control symptoms in about half of patients. Michele G.

see more →